Prosecution Insights
Last updated: October 25, 2026

Amanda Lynn Chi, USPTO Patent Examiner

Listed by the USPTO as CHI, AMANDA LYNN

Tech Center 4100 • Art Units: 1600 1611 1613 1614 1623 1626 1651 1662 4100

This examiner grants 0% of resolved cases

Performance Statistics

—
Allow Rate
-60.0% vs TC avg
44
Total Applications
—
Interview Lift
0
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

2.0%
§101 Eligibility
14.1%
§102 Novelty
41.6%
§103 Obviousness
27.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18701282 METHODS OF WEED CONTROL Final Rejection Weedout Ltd.
18832935 DISINFECTION PRODUCT BASED ON CITRIC ACID AND NATURAL NAPHTHOQUINONE COMPOUND Non-Final OA SHANGHAI JIAO TONG UNIVERSITY
18734972 FIBROUS POLYPEPTIDE-BASED BIOSCAFFOLD DELIVERY OF THERAPEUTICS TO NEURAL CELLS Non-Final OA The Regents of the University of Colorado, A Body Corporate
18543721 COMPOSITIONS CONTAINING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE AND OCTINOXATE Final Rejection L'OREAL
18216832 MONOPHASE MICELLAR COSMETIC CLEANSING COMPOSITION Non-Final OA L'OREAL
17776393 METHOD FOR CONTROLLING METABOLISM OF BRANCHED FATTY ACID Final Rejection KAO CORPORATION
18269712 FULLY-DILUTABLE, SELF-MICROEMULSIFYING DELIVERY SYSTEMS (SMEDDS) FOR POORLY WATER-SOLUBLE POLAR SOLUTES Non-Final OA THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO
18833682 OIL-IN-WATER EMULSION COSMETIC Final Rejection SHISEIDO COMPANY, LTD.
18717692 COSMETIC COMPOSITION Final Rejection SHISEIDO COMPANY, LTD.
18705656 ADHESIVE PATCH WITH COVER MATERIAL Final Rejection HISAMITSU PHARMACEUTICAL CO., INC.
18868050 COMPOSITION FOR AGRICULTURAL USE Non-Final OA Ac-Planta Inc.
18897698 INKJET PRINTING PROCESSES FOR TEMPORARY TATTOOS Non-Final OA Prism Inks, Inc.
18849392 LIQUID FORMULATIONS OF IVERMECTIN COMPOSITIONS AND USE IN GELATIN DOSAGE FORMS Non-Final OA Catalent Pharma Solutions, LLC
18847221 INHIBITOR OF CELLULAR PURINE NUCLEOTIDE SALVAGE PATHWAY ENZYME FOR USE IN THE TREATMENT AND/OR PREVENTION OF HELICOBACTER PYLORI INFECTION AND/OR DISEASE ASSOCIATED WITH SUCH INFECTION AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Non-Final OA RUÐER BOŠKOVIC INSTITUTE
18846541 A STABLE INJECTABLE COMPOSITION OF TRIAMCINOLONE ACETONIDE Non-Final OA INDOCO REMEDIES LIMITED
18844088 METHOD AND APPARATUS FOR CONTROLLING WEEDS BY POST-HARVEST TREATMENT OF WEED SEEDS Non-Final OA COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (CSURF)
18841369 NANOPREPARATION FOR JOINT ANALGESIA, AND PREPARATION METHOD AND USE THEREOF Non-Final OA Xiangya Hospital, Central South University
18804859 FORMULATIONS OF DIHYDROKAEMPFEROL Non-Final OA DEBUT BIOTECHNOLOGY, INC.
18799829 ENCASEMENT STRUCTURES FOR IMPLANTABLE DEVICES Non-Final OA Elutia Med LLC
18728203 ARTIFICIAL SKIN COMPRISING FIBROUS MAT Non-Final OA NANOSPUN TECHNOLOGIES LTD.
18610100 PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND PREPARATION COMPRISING GLUCOKINASE ACTIVATOR AND DPP-IV INHIBITOR, AND PREPARATION METHOD AND USE THEREOF Final Rejection HUA Medicine (Shanghai) Ltd.
18634518 POLOXAMER-STABILIZED REAGENTS Non-Final OA Promega Corporation
18648246 BEVERAGE TABLET AND METHOD OF CUSTOMIZING AN AQUEOUS BEVERAGE USING THE SAME Non-Final OA North Star Brands, LLC
18701457 NICOTINE CHEWING GUM Final Rejection MCNEIL AB
18587819 SHELF STABLE ORGANIC NUCLEOTIDE COMPOSITIONS AND METHODS OF MANUFACTURING THE SAME Final Rejection Glanbia Nutritionals, Inc.
18682594 Pharmaceutical Compositions Comprising Dendritic Nanocarriers and Cannabis Active Agents Non-Final OA DENDROPHARM GMBH
18420608 COOLING FORMULATION FOR TOPICAL APPLICATION Final Rejection Cold Sole, LLC
18175110 Fast Disintegrating Cannabinoid Tablets Final Rejection NordicCan A/S
17628184 A COMPOSITION COMPRISING SIMETHICONE AND SUCROSE ESTERS AND USE THEREOF AS AN ANTIFOAM AGENT Non-Final OA S.I.I.T. S.R.L. SERVIZIO INTERNAZIONALE IMBALLAGGI TERMOSALDANTI.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

Which art unit does examiner Amanda Lynn Chi work in?

Amanda Lynn Chi examines applications in Art Unit 1600 in Tech Center 4100.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month